CA1017672A - Dermatological compositions - Google Patents

Dermatological compositions

Info

Publication number
CA1017672A
CA1017672A CA167,517A CA167517A CA1017672A CA 1017672 A CA1017672 A CA 1017672A CA 167517 A CA167517 A CA 167517A CA 1017672 A CA1017672 A CA 1017672A
Authority
CA
Canada
Prior art keywords
dermatological compositions
dermatological
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA167,517A
Other versions
CA167517S (en
Inventor
Donald E. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of CA1017672A publication Critical patent/CA1017672A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
CA167,517A 1972-04-05 1973-03-29 Dermatological compositions Expired CA1017672A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24140472A 1972-04-05 1972-04-05
US340787A US3896238A (en) 1972-04-05 1973-03-13 Dermatological compositions

Publications (1)

Publication Number Publication Date
CA1017672A true CA1017672A (en) 1977-09-20

Family

ID=26934273

Family Applications (1)

Application Number Title Priority Date Filing Date
CA167,517A Expired CA1017672A (en) 1972-04-05 1973-03-29 Dermatological compositions

Country Status (3)

Country Link
US (1) US3896238A (en)
CA (1) CA1017672A (en)
IT (1) IT1053717B (en)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952099A (en) * 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4046886A (en) * 1975-01-17 1977-09-06 The Procter & Gamble Company Dermatological compositions
US4130667A (en) * 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
US4086079A (en) * 1976-04-14 1978-04-25 The Procter & Gamble Company Sulfides and derivatives thereof as abscission agents
US4146649A (en) * 1976-10-14 1979-03-27 Faberge, Incorporated Skin moisturizing composition containing a polyethoxy fatty alcohol and a polyethoxy glycoside
US4148874A (en) * 1977-06-13 1979-04-10 The Procter & Gamble Company Dermatological compositions
US4349536A (en) * 1980-03-11 1982-09-14 Hausler Kenneth J Method of promoting suntan using a cream containing zinc and copper salts
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
US4645760A (en) * 1982-07-30 1987-02-24 Health Research Inc. Activated aminoglycosides and aminoglycoside-aminocyclitols pharmaceutical compositions and method of use
US4762704A (en) * 1983-06-22 1988-08-09 Bristol-Myers Company Antiperspirant compositions, containing certain antihistamines and certain antihistamine enhancers
US4708964A (en) * 1984-02-09 1987-11-24 Chemex Pharmaceuticals Lipoxygenase inhibitors
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US5714510A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical proxyl composition and method
US5714482A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical spin labels and method
US5728714A (en) * 1985-07-18 1998-03-17 Proctor; Peter H. Method for treating hair loss using tempo
US5472687A (en) * 1985-07-18 1995-12-05 Proctor; Peter H. Topical pyridine N-oxides
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
EP0232311B1 (en) * 1985-07-18 1993-05-12 PROCTOR, Peter H. Topical composition and method for stimulating hair growth
US5716947A (en) * 1985-07-18 1998-02-10 Proctor; Peter H. Topical doxyl composition and method
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US4888362A (en) * 1987-01-16 1989-12-19 American Home Products Corp. Eugenol enhancement of transdermal drug delivery
US4888360A (en) * 1987-01-16 1989-12-19 American Home Products Corporation Carvone enhancement of transdermal drug delivery
US4873266A (en) * 1987-01-16 1989-10-10 American Home Products Corp. Menthone enhancement of transdermal drug delivery
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4946832A (en) * 1987-03-13 1990-08-07 R.I.T.A. Corporation Cosmetic base composition with therapeutic properties
US4820720A (en) * 1987-08-24 1989-04-11 Alza Corporation Transdermal drug composition with dual permeation enhancers
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US5196416A (en) * 1987-08-28 1993-03-23 Eli Lilly And Company Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
AU3554089A (en) * 1988-04-27 1989-11-24 Yale University Compositions and methods for treating cutaneous hyperproliferative disorders
US5378730A (en) * 1988-06-09 1995-01-03 Alza Corporation Permeation enhancer comprising ethanol and monoglycerides
US5641504A (en) * 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
DE4115849A1 (en) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts PENETRATION PROMOTING SUBSTANCE
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5639866A (en) * 1993-02-23 1997-06-17 Princeton University Single-step formation of multiple glycosidic linkages
RU2134693C1 (en) * 1993-02-23 1999-08-20 Зе Трастис оф Принстон Юниверсити Methods of forming glycoside bonds, chemical composition, glycoside and glycoside library
ATE149349T1 (en) * 1993-06-25 1997-03-15 Alza Corp INCORPORATING A POLY-N-VINYLAMIDE INTO A TRANSDERMAL SYSTEM
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5705164A (en) * 1995-08-03 1998-01-06 The Procter & Gamble Company Lotioned tissue paper containing a liquid polyol polyester emollient and an immobilizing agent
US5624676A (en) * 1995-08-03 1997-04-29 The Procter & Gamble Company Lotioned tissue paper containing an emollient and a polyol polyester immobilizing agent
US5607760A (en) * 1995-08-03 1997-03-04 The Procter & Gamble Company Disposable absorbent article having a lotioned topsheet containing an emollient and a polyol polyester immobilizing agent
US5609587A (en) * 1995-08-03 1997-03-11 The Procter & Gamble Company Diaper having a lotioned topsheet comprising a liquid polyol polyester emollient and an immobilizing agent
DE19537509A1 (en) * 1995-09-27 1997-04-10 Egsto Pharm Pharmazeutische Pr Prods. for treating irritated skin
AU4990797A (en) * 1996-10-24 1998-05-15 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
AU1728099A (en) 1997-12-22 1999-07-12 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
US6544541B1 (en) 1999-06-02 2003-04-08 Cardiovascular Solutions, Inc. Devices and compounds for treating arterial restenosis
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US20090162342A1 (en) * 2001-06-07 2009-06-25 Sanomune Inc. Therapeutic uses of glandular kallikrein
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
KR101407131B1 (en) * 2002-06-10 2014-06-19 유로-셀티크 소시에떼 아노뉨 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
AU2003278775B2 (en) * 2002-07-01 2010-06-17 Maria Villani Porifera-based therapeutic compositions for treating and preventing skin diseases
JP4642467B2 (en) * 2002-08-20 2011-03-02 ユーロ−セルティーク エス．エイ． Transdermal dosage form containing active agent and salt and free base form of side effect substance
US20080020028A1 (en) * 2003-08-20 2008-01-24 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
CA2641420C (en) 2006-02-03 2013-06-25 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP2073824A2 (en) * 2006-10-05 2009-07-01 Maria Villani Use of spongilla spicules as a dermabrasion device or resurfacing modality
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20090304776A1 (en) * 2008-06-06 2009-12-10 Totada Shantha Transmucosal delivery of therapeutic agents and methods of use thereof
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110117175A1 (en) * 2009-11-18 2011-05-19 Rosenbaum Richard J Sweet analgesic for use in medical procedures or treatments
EP2627335A1 (en) 2010-10-06 2013-08-21 Bio Skincare Limited Composition for skin treatment
US20130210759A1 (en) 2010-10-06 2013-08-15 Bio Skincare Limited Composition for Use in the Treatment of Acne
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
CN103619836A (en) 2011-03-03 2014-03-05 德诺瓦姆德有限公司 Antimicrobial/adjuvant compounds and methods
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
DK2854841T3 (en) 2012-06-04 2017-05-22 Diamedica Inc Kallikrein-1-glycosylation isoforms of human tissue
CN110446501A (en) 2017-03-09 2019-11-12 代阿麦迪卡股份有限公司 The dosage form of tissue kallikrein 1
EP3762376B1 (en) 2018-03-05 2023-03-01 Denovamed Inc. Diphenyl substituted thiophene-2-amide derivatives and pharmaceutical compositions thereof useful as antimicrobial

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3739031A (en) * 1958-04-01 1973-06-12 Lever Brothers Ltd Dodecyl 2-hydroxyethyl sulfoxide
US3247258A (en) * 1961-10-25 1966-04-19 Chevron Res Methyl-beta-hydroxyalkyl sulfoxides
US3232879A (en) * 1962-03-08 1966-02-01 Chevron Res Detergent bars having good sudsing and lime soap dispersant characteristics
US3288858A (en) * 1962-12-21 1966-11-29 Procter & Gamble Sulfoxides and syntheses thereof
GB1081577A (en) * 1964-06-29 1967-08-31 Procter & Gamble Scopolamine esters and acid addition salts thereof useful as anti-perspirant agents
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3678156A (en) * 1970-05-15 1972-07-18 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof

Also Published As

Publication number Publication date
IT1053717B (en) 1981-10-10
US3896238A (en) 1975-07-22

Similar Documents

Publication Publication Date Title
CA1017672A (en) Dermatological compositions
AU483797B2 (en) Dermatological compositions
CA1020464A (en) Shampoo compositions
CA1011506A (en) Softener-detergent composition
AU472941B2 (en) Pharmaceutical compositions
CA977503A (en) Rinse-wax formulation
PH15138A (en) Dermatological compositions
AU475599B2 (en) Pharmaceutical compositions
AU472176B2 (en) Composition
AU444636B2 (en) Soil-binding compositions
CA1001072A (en) Compositions zootechniques
CA1005770A (en) Protease-containg composition
CA1001920A (en) Compositions extinctrices
AU471785B2 (en) Therapeutic compositions
AU471794B2 (en) Iodophor-steroid pharmaceutical compositions
AU470518B2 (en) Dermatological compositions
AU485607B2 (en) Compositions
AU5389173A (en) Dermatological compositions
CA990880A (en) Tar-urethane composition
AU487140B2 (en) Cosmetic compositions
CA901484A (en) Cosmetic compositions
CA900354A (en) Insectiphobic compositions
CA915977A (en) Beverage-forming compositions
CA893167A (en) Amide-epoxide compositions
CA912191A (en) Lactone-silicone compositions